Skip to content
Study details
Enrolling now

Virtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cell Disease Experiencing Vaso-Occlusive Crises

University of Maryland, Baltimore
NCT IDNCT06184126ClinicalTrials.gov data as of Apr 2026
Target enrollment

30

Study length

about 2.2 years

Ages

18+

Locations

1 site in MD

About this study

Researchers are testing whether virtual reality devices can help reduce pain during vaso-occlusive crises in people with sickle cell disease. The trial will involve using a virtual reality headset and hand controllers as an addition to standard care, while also using blindfolding and noise cancellation. Patients will be asked about their pain levels at different times during the session.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Blindfolding and Noise Cancelling
  • 2.Use Virtual Reality Headset and Hand-Held Controllers
Primary goalComparison of the change in pain scores between the 3 groups at one hour after completion of the study intervention

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low6%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Endpoints

Primary: Comparison of the change in pain scores between the 3 groups at one hour after completion of the study intervention.

Secondary: Comparison of the change in pain scores between the 3 groups at completion of the study intervention., Comparison of the change in pain scores between the 3 groups at one hour after study intervention begins.

Devices

therapeutic